Top Gainers & Losers: Pharma stocks see big moves after FDA move on Cipla
In the Nifty50 universe, Divis Labs, UltraTech Cement and Tech Mahindra emerged the top gainers whereas Adani Enterprises, Cipla and Britannia were the top laggards.
Indian equity benchmarks Sensex and Nifty50 ended a volatile session in the red on Monday, extending losses to a second straight trading day, amid weakness in financial, oil & gas and FMCG shares. Globally, concerns persisted among investors over the prospect of a prolonged period of aggressive hikes in benchmark interest rates.
The Sensex settled with a cut of 311 points or 0.5 per cent at 60,691.5 and Nifty50 settled at 17,844.6, down 99 points or 0.6 per cent from its previous close.
In the Nifty50 basket, Divi’s Labs, UltraTech Cement and Tech Mahindra were the top gainers whereas Adani Enterprises, Cipla and Britannia were the top losers.
Here are some of the blue-chip stocks that made the biggest moves on February 20:
Divis Laboratories
Divi’s Labs shares gained by 2.5 per cent to end at Rs 2,902 apiece on NSE — emerging the top gainer in the Nifty50 pack for the day.
UltraTech Cement shares rose 1.5 per cent to end at Rs 7,415 apiece on BSE — the top Sensex gainer.
Cipla shares declined six per cent to settle at Rs 963 apiece on NSE. On Saturday, the drug maker said it had received eight observations from US regulator FDA for its Pithampur plant in Madhya Pradesh.
latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.